Associations between circadian misalignment and telomere length in BD: an actigraphy study.

Actigraphy Bipolar disorder Circadian Eveningness Morningness Telomere

Journal

International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983

Informations de publication

Date de publication:
27 May 2022
Historique:
received: 28 02 2022
accepted: 25 04 2022
entrez: 26 5 2022
pubmed: 27 5 2022
medline: 27 5 2022
Statut: epublish

Résumé

Life expectancy is significantly decreased in bipolar disorder (BD). This is associated with accelerated cellular aging which can be estimated by telomere length (TL). However, specific determinants of shorter TL in BD are under-explored. This study examines whether circadian misalignment (i.e. mismatch between preferred and actual phase of circadian activity rhythms) is associated with shorter TL in BD. Euthymic individuals with BD (n = 101) undertook 21 consecutive days of actigraphy recording and completed the Composite Scale of Morningness (CSM) to assess phase preference for activities (chronotype). Polymerase chain reaction was used to measure TL in blood. Cluster analysis identified circadian aligned/misaligned subgroups as defined by preferred (CSM score) and actual phases of activity (actigraphically determined onset of active and inactive periods). We tested for any associations between TL and clusters, with adjustments for between-cluster differences in socio-demographic and illness factors. We identified three clusters: an "Aligned Morning" cluster (n = 31) with preferred and actual timing of activity in the morning, an "Aligned Evening" cluster (n = 37) with preferred and actual timing of activity in the evening and a "Misaligned" cluster (n = 32) with an evening chronotype, but an earlier objective onset of active periods. After adjustment for confounders, we found that TL was significantly associated with circadian misalignment and older age. Circadian misalignment may partly explain shorter TL in BD and could contribute to accelerated aging in these individuals.

Sections du résumé

BACKGROUND BACKGROUND
Life expectancy is significantly decreased in bipolar disorder (BD). This is associated with accelerated cellular aging which can be estimated by telomere length (TL). However, specific determinants of shorter TL in BD are under-explored. This study examines whether circadian misalignment (i.e. mismatch between preferred and actual phase of circadian activity rhythms) is associated with shorter TL in BD.
METHODS METHODS
Euthymic individuals with BD (n = 101) undertook 21 consecutive days of actigraphy recording and completed the Composite Scale of Morningness (CSM) to assess phase preference for activities (chronotype). Polymerase chain reaction was used to measure TL in blood. Cluster analysis identified circadian aligned/misaligned subgroups as defined by preferred (CSM score) and actual phases of activity (actigraphically determined onset of active and inactive periods). We tested for any associations between TL and clusters, with adjustments for between-cluster differences in socio-demographic and illness factors.
RESULTS RESULTS
We identified three clusters: an "Aligned Morning" cluster (n = 31) with preferred and actual timing of activity in the morning, an "Aligned Evening" cluster (n = 37) with preferred and actual timing of activity in the evening and a "Misaligned" cluster (n = 32) with an evening chronotype, but an earlier objective onset of active periods. After adjustment for confounders, we found that TL was significantly associated with circadian misalignment and older age.
CONCLUSIONS CONCLUSIONS
Circadian misalignment may partly explain shorter TL in BD and could contribute to accelerated aging in these individuals.

Identifiants

pubmed: 35619042
doi: 10.1186/s40345-022-00260-w
pii: 10.1186/s40345-022-00260-w
pmc: PMC9135941
doi:

Types de publication

Journal Article

Langues

eng

Pagination

14

Subventions

Organisme : Fondation FondaMental
ID : Prix Face
Organisme : Fondation FondaMental
ID : Prix Marcel Dassault
Organisme : Institut National de la Santé et de la Recherche Médicale
ID : C0829
Organisme : Assistance Publique - Hôpitaux de Paris
ID : GAN12

Informations de copyright

© 2022. The Author(s).

Références

J Biol Rhythms. 2021 Oct;36(5):483-490
pubmed: 34313481
Sci Rep. 2020 Feb 13;10(1):2569
pubmed: 32054990
Bipolar Disord. 2020 Nov;22(7):693-710
pubmed: 32564457
Chronobiol Int. 2021 Jan;38(1):79-89
pubmed: 33143487
Psychiatry Res. 2018 Dec;270:41-49
pubmed: 30243131
BMC Genomics. 2019 Jan 7;20(1):14
pubmed: 30616504
Exp Gerontol. 2015 Jun;66:17-20
pubmed: 25845980
Transl Psychiatry. 2019 Mar 21;9(1):97
pubmed: 30898995
J Affect Disord. 2021 Dec 1;295:1032-1039
pubmed: 34706411
Bipolar Disord. 2019 Dec;21(8):741-773
pubmed: 31609530
Neuropsychopharmacology. 2018 Jan;43(2):454
pubmed: 29230034
Addiction. 2021 Aug;116(8):1954-1972
pubmed: 33140537
Psychoneuroendocrinology. 2019 May;103:163-172
pubmed: 30695740
Eur Neuropsychopharmacol. 2016 Jul;26(7):1241-7
pubmed: 27084304
Pharmacogenomics. 2020 Jun;21(8):533-540
pubmed: 32372689
JCI Insight. 2020 Feb 13;5(3):
pubmed: 31895695
Am J Clin Nutr. 2018 Sep 1;108(3):453-475
pubmed: 30535086
Sleep Med. 2015 May;16(5):559-63
pubmed: 25890781
Chronobiol Int. 2019 Oct;36(10):1316-1333
pubmed: 31387413
Biochem Biophys Res Commun. 2021 Aug 27;567:9-16
pubmed: 34130181
Sleep. 2019 Oct 9;42(10):
pubmed: 31270544
Bipolar Disord. 2017 Mar;19(2):84-96
pubmed: 28470927
Aviat Space Environ Med. 2000 Mar;71(3):216-24
pubmed: 10716165
Int J Environ Res Public Health. 2019 Jun 28;16(13):
pubmed: 31261650
Transl Psychiatry. 2013 May 21;3:e261
pubmed: 23695236
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
J Appl Psychol. 1989 Oct;74(5):728-38
pubmed: 2793773
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Sleep Med. 2019 Aug;60:236-247
pubmed: 31202686
Bipolar Disord. 2021 Aug;23(5):445-453
pubmed: 33650218
J Psychiatr Res. 2017 Oct;93:64-71
pubmed: 28601667
J Affect Disord. 2015 Jul 15;180:142-7
pubmed: 25909752
Biochem Pharmacol. 2021 Sep;191:114438
pubmed: 33545116
Environ Res. 2017 Oct;158:480-489
pubmed: 28704792
Cancer Med. 2017 Aug;6(8):1988-1997
pubmed: 28707432
Biomed Res Int. 2019 Apr 11;2019:8327629
pubmed: 31111068
Mamm Genome. 2016 Aug;27(7-8):332-40
pubmed: 27137838
Biology (Basel). 2019 Jul 12;8(3):
pubmed: 31336976
Sleep Med. 2021 Oct;86:90-98
pubmed: 34479052
Bipolar Disord. 2022 May;24(3):286-297
pubmed: 34486201
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
Eur Psychiatry. 1999 Sep;14(5):284-90
pubmed: 10572359
PLoS One. 2020 Mar 27;15(3):e0230674
pubmed: 32218598
Nutr Rev. 2012 Aug;70(8):459-71
pubmed: 22835139
Biol Psychiatry. 2016 Jan 15;79(2):78-86
pubmed: 25749099
Naturwissenschaften. 2016 Feb;103(1-2):3
pubmed: 26715354
Bipolar Disord. 2015 Aug;17(5):543-8
pubmed: 25846854
Science. 2015 Dec 4;350(6265):1193-8
pubmed: 26785477
FASEB J. 2015 Dec;29(12):4794-803
pubmed: 26260033
Physiol Rev. 2008 Apr;88(2):557-79
pubmed: 18391173
Int Rev Psychiatry. 2014 Apr;26(2):139-54
pubmed: 24892891
Neurosci Biobehav Rev. 2014 May;42:157-69
pubmed: 24548785
Neuropsychopharmacology. 2019 Mar;44(4):757-765
pubmed: 30559463

Auteurs

Luana Spano (L)

INSERM UMR-S 1144, Optimisation Thérapeutique en Neurospsychopharmacologie, OTeN, Université de Paris, 75006, Paris, France.

Vincent Hennion (V)

INSERM UMR-S 1144, Optimisation Thérapeutique en Neurospsychopharmacologie, OTeN, Université de Paris, 75006, Paris, France.
Université de Paris, Paris, France.
DMU Neurosciences, Département de Psychiatrie Et de Médecine Addictologique, AP-HP.Nord, GH Saint-Louis-Lariboisière-F. Widal, Paris, France.

Cynthia Marie-Claire (C)

INSERM UMR-S 1144, Optimisation Thérapeutique en Neurospsychopharmacologie, OTeN, Université de Paris, 75006, Paris, France.

Frank Bellivier (F)

INSERM UMR-S 1144, Optimisation Thérapeutique en Neurospsychopharmacologie, OTeN, Université de Paris, 75006, Paris, France.
Université de Paris, Paris, France.
DMU Neurosciences, Département de Psychiatrie Et de Médecine Addictologique, AP-HP.Nord, GH Saint-Louis-Lariboisière-F. Widal, Paris, France.

Jan Scott (J)

Université de Paris, Paris, France.
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Bruno Etain (B)

INSERM UMR-S 1144, Optimisation Thérapeutique en Neurospsychopharmacologie, OTeN, Université de Paris, 75006, Paris, France. bruno.etain@inserm.fr.
Université de Paris, Paris, France. bruno.etain@inserm.fr.
DMU Neurosciences, Département de Psychiatrie Et de Médecine Addictologique, AP-HP.Nord, GH Saint-Louis-Lariboisière-F. Widal, Paris, France. bruno.etain@inserm.fr.
Département de Psychiatrie et de Médecine Addictologique, Centre Expert Troubles Bipolaires, Hôpital Fernand Widal, 200, rue du Faubourg Saint Denis, 75010, Paris Cedex, France. bruno.etain@inserm.fr.

Classifications MeSH